Articles from InTandem Capital Partners

InTandem Capital Partners (“InTandem Capital” or the “Firm”), a healthcare services-focused private equity firm, announced today that it has partnered with the founder and management team at Clinilabs (the “Company”), a global, full-service contract research organization (CRO) dedicated to providing a complete range of central nervous system (CNS) drug and device development services to the pharmaceutical, biotechnology, and medical technology industries.
By InTandem Capital Partners · Via Business Wire · March 12, 2025

InTandem Capital Partners, LLC (“InTandem Capital” or the “Firm”), a healthcare services focused private equity firm, announced today that it has partnered with the founders and management team of Adams Clinical (the “Company”), a renowned clinical trial site network with locations across the Northeast that conducts independent evaluations of drugs to treat psychiatric and neurologic illnesses.
By InTandem Capital Partners · Via Business Wire · May 21, 2024

InTandem Capital Partners, LLC (“InTandem Capital”), a healthcare services focused private equity firm, is pleased to announce that Mehran Ahmed has joined the investment team as Partner.
By InTandem Capital Partners · Via Business Wire · December 5, 2023

InTandem Capital Partners, LLC (“InTandem Capital” or the “Firm”), a healthcare services focused private equity firm, announced today that it has completed a strategic equity investment in OrthoNebraska (the “Company”), a leading provider of musculoskeletal care and Nebraska’s first hospital dedicated to the care of the orthopedic patient.
By InTandem Capital Partners · Via Business Wire · August 2, 2023

InTandem Capital Partners, LLC (“InTandem Capital” or the “Firm”), a healthcare services focused private equity firm, announced today that it has formed beBright (the “Company”), a doctor-owned, doctor-led collaboration of several of the industry’s leading pediatric dentistry and orthodontic practices. Born from the desire to integrate patient care and practice operations across two complementary dental specialties, five foundational practices have combined to deliver a new standard in patient care and redefine the norm in dental care for patients, parents, and doctors alike.
By InTandem Capital Partners · Via Business Wire · June 27, 2023

Ivy Fertility, a nationally and internationally recognized innovator in the field of advanced reproductive technologies, in-vitro fertilization (IVF), and third-party reproduction, announced today it has acquired Fertility Associates of Memphis.
By InTandem Capital Partners · Via Business Wire · February 14, 2023

Ivy Fertility, a nationally and internationally recognized innovator in the field of advanced reproductive technologies, in-vitro fertilization, and third-party reproduction that is backed by InTandem Capital Partners, a healthcare services focused private equity firm, announced today it has acquired Utah Fertility Center, Nevada Center for Reproductive Medicine and Nevada Fertility Center, market-leading fertility services providers in the Mountain West region. The acquisition further expands Ivy Fertility’s reach into Nevada, Utah, Idaho and the Sierra Nevada region of California.
By InTandem Capital Partners · Via Business Wire · January 13, 2022

Ivy Fertility, a nationally and internationally recognized innovator in the field of advanced reproductive technologies, in-vitro fertilization, and third-party reproduction that is backed by InTandem Capital Partners, a healthcare services focused private equity firm, announced today it has acquired Pacific NW Fertility and IVF Specialists (“PNWF”), a leading fertility provider group in Seattle, WA.
By InTandem Capital Partners · Via Business Wire · January 6, 2022

InTandem Capital Partners, LLC (“InTandem Capital”), a healthcare services focused private equity firm, is pleased to announce that Brad Coppens has joined the investment team as Senior Managing Director.
By InTandem Capital Partners · Via Business Wire · July 14, 2021